S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
NASDAQ:UMRX

Cogent Biosciences News Headlines

$11.90
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.75
Now: $11.90
$12.35
50-Day Range
$2.35
MA: $10.54
$13.01
52-Week Range
$0.29
Now: $11.90
$3.72
Volume197,103 shs
Average Volume1.22 million shs
Market Capitalization$505.38 million
P/E RatioN/A
Dividend YieldN/A
Beta3.93

Headlines

Cogent Biosciences (NASDAQ UMRX) News Headlines Today

Source:
SourceHeadline
Cogent Biosciences (NASDAQ:UMRX) Reaches New 52-Week High at $12.24Cogent Biosciences (NASDAQ:UMRX) Reaches New 52-Week High at $12.24
americanbankingnews.com - January 11 at 10:20 PM
Cogent Biosciences (NASDAQ:UMRX) Sets New 1-Year High at $12.36Cogent Biosciences (NASDAQ:UMRX) Sets New 1-Year High at $12.36
americanbankingnews.com - January 4 at 8:10 PM
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational ProgressUnum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
prnewswire.com - October 5 at 12:29 PM
Unum Therapeutics now named as Cogent BiosciencesUnum Therapeutics now named as Cogent Biosciences
seekingalpha.com - October 5 at 12:29 PM
Unum Therapeutics Inc. (UMRX)Unum Therapeutics Inc. (UMRX)
finance.yahoo.com - October 1 at 2:42 PM
Blueprint Medicines Reports Positive Test Results For Rare Disease Treatment; BPMC Stock JumpsBlueprint Medicines Reports Positive Test Results For Rare Disease Treatment; BPMC Stock Jumps
finance.yahoo.com - September 22 at 2:09 PM
Unum Therapeutics BOXR CAR-T platform and products rights acquired by SOTIOUnum Therapeutics' BOXR CAR-T platform and products rights acquired by SOTIO
seekingalpha.com - August 31 at 12:42 PM
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum TherapeuticsSOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
finance.yahoo.com - August 31 at 7:39 AM
Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIOUnum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO
finance.yahoo.com - August 31 at 7:39 AM
Is Unum Therapeutics (UMRX) Stock Outpacing Its Medical Peers This Year?Is Unum Therapeutics (UMRX) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - August 25 at 2:18 PM
Thinking about buying stock in Hudson Ltd, Unum Therapeutics, GrowGeneration, TOP Ships, or Norwegian Cruise Line?Thinking about buying stock in Hudson Ltd, Unum Therapeutics, GrowGeneration, TOP Ships, or Norwegian Cruise Line?
marketwatch.com - August 19 at 12:18 PM
Venrock Healthcare Capital Partners acquires 0.451M shares of Unum TherapeuticsVenrock Healthcare Capital Partners acquires 0.451M shares of Unum Therapeutics
seekingalpha.com - August 19 at 9:43 AM
The Daily Biotech Pulse: Gileads Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOsThe Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
feeds.benzinga.com - August 19 at 8:13 AM
Unum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate UpdatesUnum Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates
finance.yahoo.com - August 11 at 8:34 PM
Arena Pharmaceuticals (ARNA) Q2 Loss Narrower Than ExpectedArena Pharmaceuticals (ARNA) Q2 Loss Narrower Than Expected
finance.yahoo.com - August 6 at 1:09 PM
Allogene's (ALLO) Q2 Loss Widens Y/Y, Pipeline ProgressesAllogene's (ALLO) Q2 Loss Widens Y/Y, Pipeline Progresses
finance.yahoo.com - August 6 at 1:09 PM
Is Unum Therapeutics (UMRX) Outperforming Other Medical Stocks This Year?Is Unum Therapeutics (UMRX) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - August 5 at 1:10 PM
Unum Therapeutics Inc. (UMRX) Outpaces Stock Market Gains: What You Should KnowUnum Therapeutics Inc. (UMRX) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - August 3 at 9:03 PM
Kaskela Law LLC Announces Investigation of Unum Therapeutics Inc. and Encourages Long-Term Investors to Contact the Firm - UMRXKaskela Law LLC Announces Investigation of Unum Therapeutics Inc. and Encourages Long-Term Investors to Contact the Firm - UMRX
finance.yahoo.com - July 21 at 10:56 AM
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Relay Therapeutics IPOThe Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Relay Therapeutics IPO
www.msn.com - July 14 at 8:27 AM
Pre-market Movers In Healthcare Sector: ANIX, BNGO, ZIOP, TRVI…Pre-market Movers In Healthcare Sector: ANIX, BNGO, ZIOP, TRVI…
www.nasdaq.com - July 10 at 10:06 AM
Unum Therapeutics rallies on disclosure of Fairmont stakeUnum Therapeutics rallies on disclosure of Fairmont stake
seekingalpha.com - July 10 at 8:39 AM
Unum Therapeutics Inc. (UMRX) Shares March Higher, Can It Continue?Unum Therapeutics Inc. (UMRX) Shares March Higher, Can It Continue?
finance.yahoo.com - July 9 at 12:15 PM
Unum Therapeutics (UMRX) Catches Eye: Stock Jumps 8.6%Unum Therapeutics (UMRX) Catches Eye: Stock Jumps 8.6%
finance.yahoo.com - July 8 at 9:40 AM
Why Unum Therapeutics Is Trading Higher TodayWhy Unum Therapeutics Is Trading Higher Today
www.benzinga.com - July 8 at 5:41 AM
Unum Therapeutics completes Kiq buy, inks $104M capital raiseUnum Therapeutics completes Kiq buy, inks $104M capital raise
seekingalpha.com - July 6 at 2:05 PM
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Unum Therapeutics Inc. for Potential Breach of Fiduciary Duty ClaimsINVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Unum Therapeutics Inc. for Potential Breach of Fiduciary Duty Claims
finance.yahoo.com - June 15 at 8:01 AM
Is Unum Therapeutics Inc. (UMRX) A Good Stock To Buy?Is Unum Therapeutics Inc. (UMRX) A Good Stock To Buy?
finance.yahoo.com - May 28 at 1:22 PM
BRIEF-Unum Therapeutics Says Terminated Employment Of Matthew Osborne, CFO, Effective As Of May 29BRIEF-Unum Therapeutics Says Terminated Employment Of Matthew Osborne, CFO, Effective As Of May 29
www.reuters.com - May 25 at 7:30 AM
Unum Therapeutics EPS beats by $0.13, beats on revenueUnum Therapeutics EPS beats by $0.13, beats on revenue
seekingalpha.com - May 11 at 9:17 PM
Unum Therapeutics Inc (UMRX) Reports Q1 Loss, Tops Revenue EstimatesUnum Therapeutics Inc (UMRX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 11 at 9:17 PM
Whats in Store for Unum Therapeutics (UMRX) Q1 Earnings?What's in Store for Unum Therapeutics' (UMRX) Q1 Earnings?
www.nasdaq.com - April 28 at 4:28 PM
What's in Store for Unum Therapeutics' (UMRX) Q1 Earnings?What's in Store for Unum Therapeutics' (UMRX) Q1 Earnings?
finance.yahoo.com - April 28 at 4:27 PM
Unum Therapeutics Strengthens and Expands Leadership TeamUnum Therapeutics Strengthens and Expands Leadership Team
www.bloomberg.com - March 31 at 10:27 PM
Unum Therapeutics Inc. (UMRX) Q4 Earnings and Revenues Beat EstimatesUnum Therapeutics Inc. (UMRX) Q4 Earnings and Revenues Beat Estimates
finance.yahoo.com - March 26 at 2:18 PM
Unum Therapeutics EPS beats by $0.35, beats on revenueUnum Therapeutics EPS beats by $0.35, beats on revenue
seekingalpha.com - March 26 at 7:57 AM
Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdatesUnum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates
finance.yahoo.com - March 26 at 7:57 AM
Unum Therapeutics inks $25M stock purchase agreement; shares up 6% premarketUnum Therapeutics inks $25M stock purchase agreement; shares up 6% premarket
seekingalpha.com - March 20 at 8:33 AM
BRIEF-FDA Puts Partial Clinical Hold On Phase 1 Trial Of Unum Therapeutics Actr707BRIEF-FDA Puts Partial Clinical Hold On Phase 1 Trial Of Unum Therapeutics' Actr707
www.reuters.com - March 9 at 6:27 PM
Unum Therapeutics down 18% on restructuringUnum Therapeutics down 18% on restructuring
seekingalpha.com - March 2 at 2:01 PM
Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor CancersUnum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cancers
finance.yahoo.com - March 2 at 9:00 AM
Unums ACTR707 shows acceptable safety profile in early-stage studyUnum's ACTR707 shows acceptable safety profile in early-stage study
seekingalpha.com - January 29 at 8:28 AM
Unum Therapeutics Provides Updates to its Phase 1 Trial of ACTR707 for HER2+ Solid Tumor CancersUnum Therapeutics Provides Updates to its Phase 1 Trial of ACTR707 for HER2+ Solid Tumor Cancers
finance.yahoo.com - January 29 at 8:27 AM
Did Changing Sentiment Drive Unum Therapeuticss (NASDAQ:UMRX) Share Price Down A Painful 77%?Did Changing Sentiment Drive Unum Therapeutics's (NASDAQ:UMRX) Share Price Down A Painful 77%?
finance.yahoo.com - January 17 at 10:44 PM
Did Changing Sentiment Drive Unum Therapeutics's (NASDAQ:UMRX) Share Price Down A Painful 77%?Did Changing Sentiment Drive Unum Therapeutics's (NASDAQ:UMRX) Share Price Down A Painful 77%?
finance.yahoo.com - January 17 at 5:44 PM
Hedge Funds Are Selling Unum Therapeutics Inc. (UMRX)Hedge Funds Are Selling Unum Therapeutics Inc. (UMRX)
finance.yahoo.com - December 22 at 8:09 PM
Unum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual MeetingUnum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 7 at 5:25 PM
Unum Therapeutics to Present at Upcoming Investor ConferenceUnum Therapeutics to Present at Upcoming Investor Conference
finance.yahoo.com - November 15 at 8:25 AM
Unum Therapeutics Inc. (UMRX) Reports Q3 Loss, Misses Revenue EstimatesUnum Therapeutics Inc. (UMRX) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - November 12 at 9:37 PM
Unum Therapeutics EPS misses by $0.04, misses on revenueUnum Therapeutics EPS misses by $0.04, misses on revenue
seekingalpha.com - November 12 at 6:46 PM
This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.